Log in

LON:MTPHMidatech Pharma Share Price, Forecast & News

GBX 31.50
-2.00 (-5.97 %)
(As of 07/14/2020)
Add
Compare
Today's Range
30.16
Now: GBX 31.50
33.50
50-Day Range
19.25
MA: GBX 25.46
86.50
52-Week Range
0.19
Now: GBX 31.50
87
Volume424,713 shs
Average Volume61,863 shs
Market Capitalization£12.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer. Midatech Pharma PLC is collaborating with universities and pharmaceutical companies to develop its platform technologies into a range of products. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.
Read More
Midatech Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.79 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1235-841575

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£674,000.00
Cash FlowGBX 20.36 per share
Book ValueGBX 83.30 per share

Profitability

Miscellaneous

Employees73
Market Cap£12.36 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 31.50
-2.00 (-5.97 %)
(As of 07/14/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive MTPH News and Ratings via Email

Sign-up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Midatech Pharma (LON:MTPH) Frequently Asked Questions

How has Midatech Pharma's stock been impacted by COVID-19 (Coronavirus)?

Midatech Pharma's stock was trading at GBX 36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MTPH shares have decreased by 12.5% and is now trading at GBX 31.50.
View which stocks have been most impacted by Coronavirus
.

How were Midatech Pharma's earnings last quarter?

Midatech Pharma PLC (LON:MTPH) released its earnings results on Tuesday, June, 16th. The company reported ($1,000.00) earnings per share (EPS) for the quarter.
View Midatech Pharma's earnings history
.

Has Midatech Pharma been receiving favorable news coverage?

News articles about MTPH stock have trended somewhat positive this week, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Midatech Pharma earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about Midatech Pharma
.

Who are some of Midatech Pharma's key competitors?

What other stocks do shareholders of Midatech Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include Aldeyra Therapeutics (ALDX), Barclays (BARC), Telefonaktiebolaget LM Ericsson (ERIC), Futura Medical (FUM), Lloyds Banking Group (LLOY), Pearson (PSON), Royal Mail (RMG), AON (AON), Angus Energy (ANGS) and Advanced Medical Solutions Group (AMS).

Who are Midatech Pharma's key executives?

Midatech Pharma's management team includes the following people:
  • Mr. Nicholas John Robbins-Cherry, CFO, Company Sec. & Director (Age 50)
  • Dr. Craig Richard Cook, CEO, COO & Director (Age 52)
  • Mr. Rob Rainey FCA MBA MA, Head of Corp. Devel.
  • Dr. Tim Sparey Ph.D., Chief Bus. Officer
  • Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the London Stock Exchange (LON) under the ticker symbol "MTPH."

How do I buy shares of Midatech Pharma?

Shares of MTPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Midatech Pharma's stock price today?

One share of MTPH stock can currently be purchased for approximately GBX 31.50.

How big of a company is Midatech Pharma?

Midatech Pharma has a market capitalization of £12.36 million and generates £674,000.00 in revenue each year. Midatech Pharma employs 73 workers across the globe.

What is Midatech Pharma's official website?

The official website for Midatech Pharma is www.midatechpharma.com.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is 65 Innovation Drive, Milton Park, ABINGDON, OX14 4RQ, United Kingdom. The company can be reached via phone at +44-1235-841575.

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.